HB1801 Combined Treatment of HER2-positive Breast Cancer
HB1801 Combined Treatment of HER2-positive Breast Cancer
Not yet recruiting · NCT07116824 · Registry updated 2025-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HB1801 Combined Treatment of HER2-positive Breast Cancer | HER2-positive Breast Cancer | Not yet recruiting | Phase 2 | 2025-08-12 | NCT07116824 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 39 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||